Chinese medical companies expanding into Indonesia's precision medicine market

Chinese Newsletters9hrs agoupdate PrintEnterprise

0 0

Jupiter Healthcare has announced that it is considering a joint venture with New Genetron Holding Limited (Genetron Health) in Singapore to develop the precision medicine market in Indonesia, Malaysia and Singapore.

The joint venture plan proposes to establish a new entity in Indonesia to focus on the design, construction and operation of clinical molecular diagnostic laboratories, with a focus on precision oncology, and, in due course, the establishment of aLocalized production lines for in vitro diagnostic reagents and kitsThe

The joint venture will work with the IndonesianWell-known hospitals and medical institutionsEstablish clinical collaboration for sample collection, product validation and early clinical application. Both parties will formJoint Board and Management TeamThe company is jointly responsible for regulatory filings and compliance in Indonesia. In the future, we plan to gradually expand toSoutheast Asian Neighboring MarketsThe

Jumbo Star Medical Currently MainDistribution of in vitro diagnostic products and production of medical films in ChinaPanhandle Health is leading the wayPrecision Tumor Platform EnterprisePossessionMulti-omics technology and FDA-approved productsThe

The partnership aims to combine Panzootics'Technical Advantageswith Superstar Medical'sChannel ExperienceAccelerationHigh-value cancer diagnosis and treatment programsLocalized landing in Indonesia and Southeast Asia.

# Chinese Capital Express